Rosiglitazone in Treating Patients With Liposarcoma
Clinical trial NCT00004180 · COMPLETED
Trial details
- NCT number
- NCT00004180
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-10-01
- Primary completion
- 2006-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.